Financial Performance Highlights (Q1FY27 Consolidated Basis)

  • Net Revenue From Operations: ₹1,274.26 Cr (15.80% YoY growth from ₹1,100.42 Cr in Q1FY26)
  • EBITDA: ₹313.11 Cr (33.10% YoY growth from ₹235.25 Cr in Q1FY26)
  • Profit Before Tax: ₹300.51 Cr (24.58% YoY growth from ₹241.22 Cr in Q1FY26)
  • Profit After Tax: ₹228.43 Cr (27.36% YoY growth from ₹179.36 Cr in Q1FY26)
  • Other Income: ₹56.31 Cr (vs ₹26.68 Cr YoY)
  • Foreign Exchange Fluctuation Loss: ₹(25.20) Cr (vs gain of ₹9.76 Cr YoY)
  • Finance Costs: ₹22.41 Cr (vs ₹15.83 Cr YoY)
  • Tax Expenses: ₹72.08 Cr (vs ₹61.86 Cr YoY)

Standalone Financial Performance (Q1FY27)

  • Net Revenue From Operations: ₹1,274.26 Cr (15.80% YoY growth)
  • Gross Profit: ₹470.09 Cr (18.60% YoY growth)
  • EBITDA: ₹301.36 Cr (28.80% YoY growth)
  • Profit After Tax: ₹223.42 Cr (22.37% YoY growth)

New Business Updates and Capacity Expansion

Carbon Nano Tube (CNT)

  • First commercial CNT production in India
  • Capacity: 200 MTPA
  • Capex: ₹70 Cr
  • Operational commencement: Q4FY27
  • Applications: Lithium-ion batteries, electronics, semiconductors, conductive films, sensors, aerospace, automotive

Super Speciality Carbon Black (SSCB)

  • Conversion of existing carbon black to high-value SSCB
  • Capacity: 6,000 MTPA
  • Capex: ₹170 Cr
  • Operational commencement: Q4FY28
  • Benefits: Premium realization, higher margins, entry into high-value segment

LFP Cathode Active Material

  • Capacity: 40,000 MTPA (Phase 1)
  • Capex: ₹1,125 Cr
  • Demo capacity (2,000 MTPA) commissioning: Q3FY27
  • First commercial LFP CAM facility globally ex-China

Speciality Chemicals (Anthraquinone & Carbazole)

  • Phase 1: 2,600 MTPA capacity, completion by Q2FY27
  • Phase 2: 2,700 MTPA capacity, completion by Q2FY28
  • Total capacity: 5,300 MTPA
  • Capex: ₹248 Cr
  • India's first commercial carbazole plant

Birla Tyres Acquisition

  • Strategic partnership with Resolution Applicant DBRL, acquired October 2023
  • Plant recommissioned; integration on track
  • Current distribution: 49 Distributors (40 Domestic + 9 Global) & 1000+ Dealers
  • 145+ SKUs launched
  • PCR segment entry for EVs and SUVs targeted by FY28

Strategic Investments

International Battery Company (IBC)

  • 19.44% stake with Nominee Director position
  • Transitioned from pre-revenue to revenue generating in FY2024-25
  • India Gigafactory commercial operations on track for Q4FY27
  • Product roadmap includes Prabal 2000 (LFP-graphite), Prabal 3000 (High-Ni NMC), and Advanced 2170 cells

Sicona Battery

  • Developing silicon-carbon (SiCx®) anode platform
  • Secured AUD 45 million ARENA funding
  • 39 global OEMs and cell manufacturers under NDA, 14 active qualification programs

Invati Creations

  • Multiple patents in novel molecule synthesis
  • Revenue traction since 2025, India capacity expansion underway

Sustainability Performance (FY26 Results)

  • Loss Time Injury Frequency Rate: 0 (target <1)
  • Energy intensity reduction: -19.31% (target -20%)
  • Scope 1 & 2 CO2e emission intensity reduction: -38.18% (target -30%)
  • Scope 3 CO2e emission intensity reduction: -17.17% (target -8%)
  • Zero Liquid Discharge status: 100% maintained
  • Gender diversity in management: 6.14% (target 6.5%)

Recent Awards and Recognitions

  • Featured in Burgundy Private Hurun India 500 (2025)
  • Best Overall Sustainable Performance at 14th Golden Globe Tiger Awards 2026
  • International Safety Award (ISA) 2026 – Merit from British Safety Council
  • Sustainability Report wins Platinum at LACP 2025/26 Spotlight Awards
  • Great Place to Work® certification
  • ISCC PLUS certification for Mahistikry plant
  • Golden Peacock Award for Occupational Health & Safety 2025
  • 4 awards at Chemconnect 2026 including Sustainability Leader of the Year
  • India's Top Value Creator 2025 – Chemicals by Dun & Bradstreet India
  • Champion Award in CSR at 19th EXCEED Environment Award 2025

Forward-looking Statements

The presentation contains forward-looking statements regarding market opportunity, business prospects, and growth expectations subject to risks and uncertainties including Indian and global economic performance, industry competition, technological changes, and market risks.